118. Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):14. doi: 10.1007/s11912-017-0646-x.Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition ofthe EDIFICE Survey.Viguier J(1), Morère JF(2), Pivot X(3), Touboul C(4), Lhomel C(5), Couraud S(6), de La Motte Rouge T(7), Eisinger F(8)(9).Author information: (1)CCDC 37, Hôpital Bretonneau, 2 Boulevard Tonnellé, 37044, Tours Cedex 9,France. jviguier@institutcancer.fr.(2)INSERM U1193 Département d'oncologie Médicale, Hôpital Paul Brousse, 12 avenuePaul Vaillant Couturier, 94804, Villejuif, France.(3)Centre de lutte contre le cancer Paul Strauss de Strasbourg, HôpitauxUniversitaires de Strasbourg, 3 Rue de la Porte de l'Hôpital, 67 065, Strasbourg Cedex, France.(4)Kantar Health, 3 Avenue Pierre Masse, 75014, Paris, France.(5)Roche SAS, 30 cours de l'île Seguin, 92650, Boulogne-Billancourt, France.(6)Service de Pneumologie Aiguë Spécialisée et Cancérologie Thoracique, Centrehospitalier Lyon Sud, 165 chemin du Grand Revoyet, 69495, Pierre Bénite Cedex,France.(7)Département d'oncologie médicale, Centre Eugène Marquis, Avenue de la BatailleFlandres-Dunkerque, 35000, Rennes, France.(8)INSERM, IRD, SESSTIM, Aix Marseille University, 23 rue Stanislas Torrents,13006, Marseille, France.(9)Département d'Anticipation et de Suivi du Cancer DASC, InstitutPaoli-Calmettes, 232 Boulevard Sainte Marguerite, BP 156, 13273, Marseille Cedex 9, France.BACKGROUND: The EDIFICE surveys have assessed cancer screening behavior in theFrench population since 2005.METHODS: The 2016 edition was conducted among a representative sample of 1501individuals (age, 50-75 years). The current analysis focuses on breast,colorectal, prostate, lung, and cervical cancer screening.RESULTS: The rate of women (50 to 74 years) declaring having had at least onebreast cancer screening test in their lifetime remained stable and high between2005 and 2016. Compliance with recommended screening intervals improved between2005 and 2011 from 75 to 83%, respectively, then decreased significantly to 75%in 2016 (P = 0.02). Uptake of at least one lifetime colorectal cancer screeningtest procedure declared (individuals aged 50-74 years) increase from 25% in 2005 to 59% in 2011, stabilized at 60% in 2014, then reached 64% in 2016.Opportunistic prostate cancer screening (men aged 50-75 years) rose between 2005 and 2008 from 36 to 49%, plateaued until 2014 then dropped to 42% in 2016. Theproportion of women aged 50-65 declaring having undergone one cervical cancerscreening test dropped significantly between 2014 and 2016 from 99 to 94%(P < 0.01). Lastly, 11% of our survey population in 2014 and 2016 (55-74 years)declared having already undergone lung cancer screening.CONCLUSION: Cancer screening behavior fluctuates in France, regardless of thecontext, i.e., organized programs or opportunistic screening. This observationhighlights the need for constant analysis of population attitudes to optimizepublic awareness campaigns.DOI: 10.1007/s11912-017-0646-x PMID: 29508088 